Print Page     Close Window     

SEC Filings

S-3
SEELOS THERAPEUTICS, INC. filed this Form S-3 on 02/01/2019
Entire Document
 

Audit Committee

Our audit committee currently consists of Richard W. Pascoe (Chair), Brian Lian, Ph.D. and Daniel J. O'Connor, J.D. All are non- employee directors and are considered independent under the applicable independence standard promulgated by Nasdaq and the SEC. Our Board of Directors has currently designated Mr. Pascoe as an "audit committee financial expert" as defined in Item 407(d)(5)(ii) of Regulation S-K. We believe that the audit committee members are capable of analyzing and evaluating our financial statements and understanding internal controls over financial reporting.

 

 

 

 

 

 

38



© Apricus Biosciences, Inc.